126 related articles for article (PubMed ID: 1435320)
1. Interaction of nucleotide affinity analog 5'-p-fluorosulfonylbenzoyladenosine with platelet ADP receptor: aggregin.
Figures WR; Scearce LM; Colman RF; Colman RW
Methods Enzymol; 1992; 215():143-55. PubMed ID: 1435320
[No Abstract] [Full Text] [Related]
2. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
4. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
6. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding.
Figures WR; Scearce LM; Wachtfogel Y; Chen J; Colman RF; Colman RW
J Biol Chem; 1986 May; 261(13):5981-6. PubMed ID: 3009439
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation: role of an ADP receptor.
Colman RW
Semin Hematol; 1986 Apr; 23(2):119-28. PubMed ID: 3010469
[No Abstract] [Full Text] [Related]
9. Biotinylated fibrinogen. A novel probe for monitoring post-ligand-binding events in platelets.
Hogan M; Mattson JC; Estry DW; Klomparens K
Ann N Y Acad Sci; 1994 Apr; 714():282-6. PubMed ID: 8017780
[No Abstract] [Full Text] [Related]
10. Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activation.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Arch Biochem Biophys; 1988 Apr; 262(1):298-306. PubMed ID: 3281588
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
Puri RN; Colman RW
Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
[TBL] [Abstract][Full Text] [Related]
12. Aggregin: a platelet ADP receptor that mediates activation.
Colman RW
FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
[TBL] [Abstract][Full Text] [Related]
13. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
Puri RN; Colman RW
Arch Biochem Biophys; 1997 Nov; 347(2):263-70. PubMed ID: 9367534
[TBL] [Abstract][Full Text] [Related]
14. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of an ADP receptor mediating platelet activation.
Colman RW; Figures WR
Mol Cell Biochem; 1984; 59(1-2):101-11. PubMed ID: 6323960
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence for the interaction of the nucleotide affinity analog 5'-p-fluorosulfonylbenzoyl adenosine with a platelet ADP receptor.
Figures WR; Scearce LM; DeFeo P; Stewart G; Zhou F; Chen J; Daniel J; Colman RF; Colman RW
Blood; 1987 Sep; 70(3):796-803. PubMed ID: 3040157
[TBL] [Abstract][Full Text] [Related]
18. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
Puri RN; Colman RW
Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
[TBL] [Abstract][Full Text] [Related]
19. Aggregin: the platelet receptor mediating activation by ADP.
Colman RW; Puri RN; Zhou FX; Colman RF
Prog Clin Biol Res; 1988; 283():263-77. PubMed ID: 3211953
[No Abstract] [Full Text] [Related]
20. Identification of two distinct adenosine diphosphate receptors in human platelets.
Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]